Bergamo Nephrologic Diabetes Complications Trial - BENEDICT

Description:

The goal of the trial was to evaluate treatment with the angiotensin-converting enzyme (ACE) inhibitor trandolapril, the calcium channel blocker verapamil, or the combination of the two compared with placebo among patients with hypertension, type 2 diabetes, and normal urinary albumin excretion.